<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146477">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02146586</url>
  </required_header>
  <id_info>
    <org_study_id>CNMC0713</org_study_id>
    <nct_id>NCT02146586</nct_id>
  </id_info>
  <brief_title>Clinical Evaluator Outcomes Reliability Study</brief_title>
  <official_title>Cooperative International Neuromuscular Research Group (CINRG) Clinical Evaluator Outcomes Reliability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cooperative International Neuromuscular Research Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Foundation to Eradicate Duchenne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cooperative International Neuromuscular Research Group</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study outlines structured Clinical Evaluator (CE) testing techniques that are proposed
      to be implemented across all sites participating in the Cooperative International
      Neuromuscular Research Group (CINRG) research studies. The study will determine if the
      selected techniques are reliable and reproducible across the CINRG network by evaluating the
      reliability and reproducibility of the measures between CEs
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Clinical Evaluator Assessments</measure>
    <time_frame>One time visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>The following assessments are conducted by certified physical therapists: Anthropometrics, goniometry, Brooke upper extremity and Vignos lower extremity scales, Performance Upper Limb Scale (PULS), North Star Ambulatory Assessment (NSAA), Six Minute Walk Test (6MWT), time to rise from floor, time to stand from a chair, time to climb four stairs, time to walk/run 10 meters, 9 Hole Peg Test (9HPT), Quantitative Muscle Tests (QMT), Manual Muscle testing (MMT), Force Vital Capacity (FVC), Force Expiratory Volume (FEV1), Maximum Inspiratory Pressure (MIP), Maximum Expiratory Pressure (MEP),  Peak Expiratory Flow Rate (PEFR) and Peak Cough Flow (PCF).
The reliability of these commonly used measurements is fundamental to clinical research, our ability to have confidence in the data we collect and our ability to draw rational conclusions from the data.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Dystrophinopathies</condition>
  <arm_group>
    <arm_group_label>Dystrophinopathies</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Gold Standard Clinical Evaluators (GS-CEs)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Sites Clinical Evaluators (CEs)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Dystrophinopathies (Duchenne Muscular Dystrophy and Becker Muscular Dystrophy)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Dystrophinopathy Participant Inclusion Criteria:

          -  Site confirmed genetic diagnosis of a dystrophinopathy

          -  Aged 6 years and older

          -  Able to transfer to testing table

          -  Able to walk 10 meters without an assistive device

        Dystrophinopathy Participant Exclusion Criteria:

          -  Investigator assessment of inability to comply with protocol assessments

          -  Participants who have attention deficient disorder or other cognitive conditions that
             may limit attention span to perform protocol assessments
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tina Duong, MPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julaine Florence, PT, DPT</last_name>
    <role>Study Chair</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zoe Sund, BSc (hons)</last_name>
    <phone>202-476-4110</phone>
    <email>zsund@childrensnational.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tina Duong, MPT</last_name>
    <phone>202-476-6065</phone>
    <email>tduong@childrensnational.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington DC</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bemnete Tadesse</last_name>
      <phone>202-476-4802</phone>
      <email>BTadesse@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Marisa Birkmeier, PT, DPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gina Chambers</last_name>
      <phone>612-625-4882</phone>
      <email>gchamber@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Jamie Marsh, DPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Westmead</name>
      <address>
        <city>Sydney</city>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kayla Cornett</last_name>
      <phone>(02) 9845 1328</phone>
      <email>kayla.cornett@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Apollo Children's Hospital</name>
      <address>
        <city>Chennai</city>
        <zip>600006</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Niroshan K</last_name>
      <phone>91-9841815609</phone>
      <email>niroshan.k@aherf-smo.org</email>
    </contact>
    <investigator>
      <last_name>Priya Reddappa, MPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Australia</country>
    <country>India</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>May 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
